People

Former U.S. Surgeon General Joins Eko Health as Distinguished Medical Advisor

Dr. Jerome Adams will provide strategic guidance on clinical implementation, product development, and public health partnerships.

By: Michael Barbella

Managing Editor

Former U.S. Surgeon General Jerome Adams, M.D. Photo: U.S. Department of Health & Human Services.

Eko Health has welcomed former U.S. Surgeon General Jerome Adams, M.D., as a Distinguished Medical Advisor. A board-certified anesthesiologist, and executive director of the Center for Community Health Enhancement and Learning at Purdue University, Dr. Adams has decades of clinical, public health, and policy leadership.

“I’m proud to join Eko at a pivotal moment for both the company and our broader healthcare system,” Dr. Adams stated. “Eko is transforming how we detect cardiovascular disease—making AI-powered tools accessible to frontline providers in the communities that need them most. This is how we close gaps in care, improve outcomes, and ultimately save lives.”

During his tenure as Surgeon General, Dr. Adams issued influential advisories on maternal health and hypertension—two of the most pressing drivers of poor cardiovascular outcomes, particularly in underserved communities. These focus areas directly align with Eko’s mission to bring early, artificial intelligence (AI)-powered detection tools to the frontlines of care, where timely intervention can have the greatest impact. He also issued key guidance on the opioid epidemic and the connection between community health and economic prosperity. A frequent national media contributor, Dr. Adams remains a vocal advocate for diversity, equity, and inclusion as essential pillars of public health.

In his role with Eko, Dr. Adams will provide strategic guidance on clinical implementation, product development, and public health partnerships. He will also advise on efforts to bring affordable, high-performance cardiac screening to everyday care, making earlier and more accurate detection possible in primary care settings that have not traditionally had access to specialist-level tools.

“Dr. Adams brings an exceptional combination of clinical insight, government leadership, and public health experience,” Eko Health Co-Founder/CEO Connor Landgraf said. “He knows how to turn medical innovation into real-world impact, and his perspective on expanding access, efficiency, and quality of care will be invaluable as we build on one of the largest deployments of AI-enabled medical devices in the world to reach even more clinicians and patients.”

In addition to his administrative role at Purdue, Dr. Adams is a Distinguished Professor of Practice in Pharmacy Practice and Public Health. During his tenure as Surgeon General, he issued influential advisories on naloxone and the opioid epidemic, maternal health, hypertension control, and the link between community health and economic prosperity. A frequent national media contributor, he is a vocal advocate for diversity, equity, and inclusion as public health imperatives.

With Dr. Adams’s expertise, Eko is deepening its focus on clinical excellence and expanding health equity on a global scale. Recent research highlights the potential value of Eko’s technology in enabling earlier detection of congenital heart disease in low-resource settings, ensuring children with life-threatening conditions receive timely care. In Nigeria, a randomized controlled trial published in Nature Medicine demonstrated the platform’s ability to improve detection of peripartum cardiomyopathy among pregnant women. In the United States, Eko’s collaboration with HeartSense is expanding access to structural heart disease detection in underserved communities, giving providers actionable insights that can change the course of a patient’s care.

Eko Health is an AI early disease detection company advancing the way in which healthcare professionals detect and monitor heart and lung disease with its portfolio of digital stethoscopes and ECG devices, patient and provider software, and AI-powered analysis. Its U.S. Food and Drug Administration-cleared platform, with more than 650,000 devices sold to providers globally, allows them to detect earlier and with higher accuracy, manage treatment effectively, and ultimately give their patients the best care possible. Eko Health is headquartered in Emeryville, Calif.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters